Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures

An emerging cellular immunotherapy for cancer is based on the cytolytic activity of natural killer (NK) cells against a wide range of tumors. Although in vitro activation, or “priming,” of NK cells by exposure to pro-inflammatory cytokines, such as interleukin (IL)-2, has been extensively studied, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabry, May, Zubiak, Agnieszka, Hood, Simon P., Simmonds, Poppy, Arellano-Ballestero, Helena, Cournoyer, Eily, Mashar, Meghavi, Pockley, A. Graham, Lowdell, Mark W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594622/
https://www.ncbi.nlm.nih.gov/pubmed/31242243
http://dx.doi.org/10.1371/journal.pone.0218674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594622/
https://www.ncbi.nlm.nih.gov/pubmed/31242243
http://dx.doi.org/10.1371/journal.pone.0218674

Ejemplares similares